Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03515798
Title Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer (PELICAN)
Acronym PELICAN
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Paoli-Calmettes
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Clinique de L'Europe Amiens France Details
Institut Sainte Catherine Avignon France Details
Institut BERGONIE Bordeaux France Details
CENTRE Francois Baclesse Caen France Details
Centre Georges Francois Leclerc Dijon 21079 France Details
Centre Leon Berard Lyon France Details
Institut Curie Paris France Details
Centre Henri Becquerel Rouen France Details
Institut Curie hopital rene huguenin Saint-Cloud France Details
Institut de cancérologie de la loire Saint-Priest-en-Jarez France Details
Centre Paul Strauss Strasbourg France Details
IUCT-Oncopole Institut Claudius Rigaud Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field